Cargando…
Fasentin diminishes endothelial cell proliferation, differentiation and invasion in a glucose metabolism-independent manner
The synthetic compound fasentin has been described as a modulator of GLUT-1 and GLUT-4 transporters, thus inhibiting glucose uptake in some cancer cells. Endothelial glucose metabolism has been recently connected to angiogenesis and it is now an emerging topic in scientific research. Indeed, certain...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145862/ https://www.ncbi.nlm.nih.gov/pubmed/32273578 http://dx.doi.org/10.1038/s41598-020-63232-z |